ReviewAdvances in pharmacology (San Diego, Calif.)2025

Inhibition of brain glutamate carboxypeptidase II (GCPII) to enhance cognitive function.

Robyn Wiseman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.